What's new

India Developing, but still a long way to go

.
C5lKFqiVUAAZB3N.jpg

'Mumbai richest Indian city with total wealth of USD 820 bn'

India's financial capital Mumbai, which is home to 46,000 millionaires and 28 billionaires, is the richest Indian city with a total wealth of USD 820 billion, says a report.

According to New World Wealth, Mumbai is the richest city in the country followed by Delhi and Bengaluru in the second and third place, respectively.

Delhi is home to 23,000 millionaires and 18 billionaires with a total wealth of USD 450 billion, while Bengaluru with a total wealth of USD 320 billion houses 7,700 millionaires and 8 billionaires.

The list also includes Hyderabad with a total wealth of USD 310 billion. Hyderabad is home to 9,000 millionaires and 6 billionaires.

Kolkata home to 9,600 millionaires and 4 billionaires has a total wealth of USD 290 billion, Pune (total wealth of USD 180 billion, has 4,500 millionaires and 5 billionaires), Chennai (USD 150 billion, 6,600 millionaires, 4 billionaires) and Gurgaon (USD 110 billion with 4,000 millionaires and 2 billionaires).

Some of the other emerging cities in terms of total wealth include, Surat, Ahmedabad, Visakhapatnam, Goa, Chandigarh, Jaipur and Vadodara.

The total wealth held in the country amounts to USD 6.2 trillion (as of December 2016) and the country is home to 264,000 millionaires and 95 billionaires in total.

"Over the next decade, India is expected to benefit from strong growth in the local financial services, IT, real estate, healthcare and media sectors. In particular, the local hospital services and health insurance sectors are expected to grow strongly. Hyderabad, Pune and Bangalore are expected to lead the pack in terms of wealth growth," the report said.

Millionaires or High Net Worth Individuals (HNWIs) refer to individuals with net assets of USD 1 million or more.

The report also jotted down some of the affluent suburbs in the country. In Mumbai localities like Bandra, Juhu, Goregaon, Parel, Worli, Palm Beach Road were named as the richest, in Delhi it was (Westend Greens, Dera Mandi, Greater Kailash, Lutyens), in Kolkata (Ballygunge, Alipore) and in Chennai (Boat Club Road, Poes Garden).

^^^
I am thinking:
  • Mumbai (Bombay) alone is nearly 2.5-3 times entire Pakistan economy, comments ?
This discrepancy is disproportionate and I am thinking, must be of relatively recent mint.

Pakistan is in the vast majority Punjab and Sindh. Indian Punjab and Gujarat;
the Indian parallel's to the above are and have always been rich.
 
Last edited:
. . .
.
Medanta Cyberknife

The CyberKnife VSI Robotic Radiosurgery System is an incisionless alternative to surgery for the treatment of both cancerous and non-cancerous tumours anywhere in the body, including the Prostate, Lung, Brain, Spine, Liver, Pancreas and Kidney


@war&peace @ziaulislam @1ronfury @AmirPatriot @CHACHA"G" @Basel @Well.wisher @Syed.Ali.Haider @Han Patriot @raptor22 @Solomon2 @ghazi52 @ThinkLogically @Dil Pakistan @Beast
considered worse than general surgery due to scaring, RDS in lungs, unless difficult to acess lesion or patient to weak to go surgery, in that case newer chemo therapies are much better

the approach is getting out of favor but probably still has some usage in prostate cancer but in that case simpler process like placing radioactive seeds is as effective and safe as this procedure is.

when it comes to brain, the approach used is whole brain radiaition.

i am afraid this could be money making ploy rather than actual evidence base treatment
 
.
I don't want to break your dream, but cyberknife is from Accuray, a US company. China has a similar system using soundwave, exported to UK recently.

yes yes....

http://www.globaltimes.cn/content/1063486.shtml

Indian Pharma industry

India is the largest provider of generic drugs globally with the Indian generics accounting for 20 per cent of global exports in terms of volume

Presently over 80 per cent of the antiretroviral drugs used globally to combat AIDS (Acquired Immuno Deficiency Syndrome) are supplied by Indian pharmaceutical firms.

The UN-backed Medicines Patent Pool has signed six sub-licences with Aurobindo, Cipla, Desano, Emcure, Hetero Labs and Laurus Labs, allowing them to make generic anti-AIDS medicine TenofovirAlafenamide (TAF) for 112 developing countries.

India’s pharmaceutical exports stood at US$ 16.4 billion in 2016-17 and are expected to grow by 30 per cent over the next three years to reach US$ 20 billion by 2020, according to the Pharmaceuticals Export Promotion Council of India (PHARMEXCIL).

Indian companies received 55 Abbreviated New Drug Application (ANDA) approvals and 16 tentative approvals from the US Food and Drug Administration (USFDA) in Q1 of 2017. The USFDA approvals are expected to cross 700 ANDA in 2017, thereby recording a year-on-year growth of 17 per cent. The country accounts for around 30 per cent (by volume) and about 10 per cent (value) in the US$ 70-80 billion US generics market.

Some of the major investments in the Indian pharmaceutical sector are as follows:-

  • The exports of Indian pharmaceutical industry to the US will get a boost in FY18, as branded drugs worth US$ 50 billion will become off-patented. #
  • Private equity and venture capital (PE-VC) investments in the pharmaceutical sector have grown at 38 per cent year-on-year between January-June 2017, due to major deals in this sector.
  • Indian pharmaceutical firm, Eric Lifesciences Pvt Ltd, has launched its initial public offering (IPO) worth Rs 2,000 crore (US$ 311 million) in June 2017.
  • Indian pharmaceutical company, Cadila Healthcare Ltd, is planning to raise Rs 1,000 crore (US$ 155 million) via a qualified institutional placement (QIP) of shares shortly.
  • Capital International Group, a private equity fund, has acquired a three per cent stake in Intas Pharmaceuticals Ltd from ChrysCapital Llc for a consideration of US$ 107 million, thereby valuing Intas Pharma at approximatively US$ 3.5 billion.
  • Aurobindo Pharma Ltd, has acquired four biosimilar products from Swiss firm TL Biopharmaceutical AG, which will require TL Biopharmaceutical to supply all the developmental data for four molecules, which will be developed, commercialised and marketed by Aurobindo Pharma
  • Piramal Enterprises Ltd acquired a portfolio of spasticity and pain management drugs from UK-based specialty biopharmaceutical company Mallinckrodt Pharmaceuticals, in an all-cash deal for Rs1,160 crore (US$ 171 million).
  • Aurobindo Pharma has bought Portugal based Generis Farmaceutica SA, a generic drug company, for EUR 135 million (US$ 144 million).
  • Sun Pharmaceutical Industries Ltd, India's largest drug maker, has entered into an agreement with Switzerland-based Novartis AG, to acquire the latter’s branded cancer drug Odomzo for around US$ 175 million.
  • Kedaara Capital Advisors LLP, a private equity (PE) firm, plans to invest Rs 430 crore (US$ 64.5 million) to acquire a minority stake in Hyderabad-based diagnostics chain Vijaya Diagnostic Centre Pvt Ltd.
  • Sun Pharmaceuticals Industries Limited plans to acquire 85.1 per cent stake in Russian company Biosintez for US$ 24 million for increasing its presence in Russia through local manufacturing capability.
  • Abbott Laboratories, a global drug maker based in US, plans to set up an innovation and development center (I&D) in Mumbai, which will help in developing new drug formulations, new indications, dosing, packaging and other differentiated offerings for Abott's global branded generics business.
 
. . .
. .
@Shakuni & Ravan/@Mr. Nair, clearly, no one can stop you from being a stubborn old mule as far as your rather annoying habit of tagging random people like a desperate ‘like-farmer’ goes, but posting pics of KLM Bombay crew is ‘India developing’ according to you? Before you even attempt to defend your imbecilic post, you should know that KLM has only re-entered the AMS-Bombay-AMS market, meaning, it’s not an all-new airline for the city/country.
 
.
Trivandrum

a1.jpg


Indian students in US dwarf America’s FDI in India, spend whopping $6.54 bn

---------------------------------------------------

Indian students spent a massive $6.54 billion in the US in 2016-17, up 30% from the previous year, dwarfing the North American country’s foreign direct investment (FDI) of $2.37 billion in India

Chinese students spent $12.55 billion in the US in 2016-17, up about 10%.

students from India and China now represent approximately 50% of the total enrolment of 1.08 million international students in the US. Indian students comprise 17.3% of all international students in the US, it added

About 1.08 million international students studying at US colleges and universities contributed $36.9 billion and supported more than 450,000 jobs to its economy during 2016-2017, said NAFSA, an association of international educators.

Interestingly, the number of US students coming to India to study for academic credit at their home university has been on the decline since 2013-14 and it fell by 5.8% to 4,181 in 2015-16, as they increasingly prefer European countries.

http://www.financialexpress.com/indi...-54-bn/931755/

@Moonlight @Gryphon @Well.wisher @New World @Path-Finder @Assasin Ezio @Signalian @RiazHaq @django @313ghazi @RealNapster @DavidSling @Mrc @Hamartia Antidote @fitpOsitive @Pluralist
 
.
Trivandrum

View attachment 437343

Indian students in US dwarf America’s FDI in India, spend whopping $6.54 bn

---------------------------------------------------

Indian students spent a massive $6.54 billion in the US in 2016-17, up 30% from the previous year, dwarfing the North American country’s foreign direct investment (FDI) of $2.37 billion in India

Chinese students spent $12.55 billion in the US in 2016-17, up about 10%.

students from India and China now represent approximately 50% of the total enrolment of 1.08 million international students in the US. Indian students comprise 17.3% of all international students in the US, it added

About 1.08 million international students studying at US colleges and universities contributed $36.9 billion and supported more than 450,000 jobs to its economy during 2016-2017, said NAFSA, an association of international educators.

Interestingly, the number of US students coming to India to study for academic credit at their home university has been on the decline since 2013-14 and it fell by 5.8% to 4,181 in 2015-16, as they increasingly prefer European countries.

http://www.financialexpress.com/indi...-54-bn/931755/

@Moonlight @Gryphon @Well.wisher @New World @Path-Finder @Assasin Ezio @Signalian @RiazHaq @django @313ghazi @RealNapster @DavidSling @Mrc @Hamartia Antidote @fitpOsitive @Pluralist
I didnt know that, till I my self visited a country for study. I saw groups after groups of foriegn students, landing there, having already spent lot of money to come to that country. Education was "free" though. :)
 
. .
Back
Top Bottom